Cliona M. Rooney

Thoresby Place
Leeds, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 145 publications

Adoptive T-Cell Immunotherapy.

Adoptive T-Cell Immunotherapy.

Journal: Current topics in microbiology and immunology

Published: May 27, 2026

Macrophages as gatekeepers of glioma progression.

Macrophages as gatekeepers of glioma progression.

Journal: Molecular therapy. Oncology

Published: April 20, 2026

Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.

Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 31, 2026

Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study.

Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 05, 2025

Constitutive IL-7 signaling promotes CAR-NK cell survival in the solid tumor microenvironment but impairs tumor control.

Constitutive IL-7 signaling promotes CAR-NK cell survival in the solid tumor microenvironment but impairs tumor control.

Journal: Journal for immunotherapy of cancer

Published: June 21, 2025

Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial.

Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial.

Journal: Nature medicine

Published: May 16, 2025

Multi-parametric profiling of IL-7-augmented GD2.CART products in a phase 1 clinical trial.

Multi-parametric profiling of IL-7-augmented GD2.CART products in a phase 1 clinical trial.

Journal: iScience

Published: May 05, 2025

Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b.

Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b.

Journal: Cancer immunology research

Published: February 03, 2025

Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas.

Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas.

Journal: Blood advances

Published: October 10, 2024

Differential EBV protein-specific antibody response between responders and non-responders to EBVSTs immunotherapy.

Differential EBV protein-specific antibody response between responders and non-responders to EBVSTs immunotherapy.

Journal: bioRxiv : the preprint server for biology

Published: August 30, 2024

Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.

Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 21, 2024

Eighteen-year survival after GD2-directed Chimeric Antigen Receptor-Modified Immune Effector Cell Treatment for Neuroblastoma.

Eighteen-year survival after GD2-directed Chimeric Antigen Receptor-Modified Immune Effector Cell Treatment for Neuroblastoma.

Journal: Research square

Published: April 25, 2024

Showing 1-12 of 145

Last Updated: 09/26/2026